Quick Takeaways
- Immunome Aggregator, LP filed SCHEDULE 13D/A for IMMUNOME, INC. Common Stock, par value $0.0001 per share (IMNM).
- Disclosed ownership: 6%.
- Date of event: 31 Jan 2025.
Immunome Aggregator, LP - 31 Jan 2025 SCHEDULE 13D/A Report for IMMUNOME, INC. Common Stock, par value $0.0001 per share (IMNM)
- Filing Manager
- Immunome Aggregator, LP
- Reporting Manager
- Immunome Aggregator, LP
- Symbol
- IMNM
- Shares outstanding
- 79,476,383 shares
- Disclosed Ownership
- 4,768,583 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13D/A
- Filing time
- 04 Feb 2025, 17:44:33 UTC
- Date of event
- 31 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Immunome Aggregator, LP disclosed 6% ownership in IMMUNOME, INC. Common Stock, par value $0.0001 per share (IMNM) on 31 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Feb 2025, 17:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Immunome Aggregator, LP | 6% | 4,768,583 | 0 | 4,768,583 | /s/ James P. Boylan | By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager | 0001996276 |
| Enavate Sciences GP, LLC | 6% | 4,768,583 | 0 | 4,768,583 | /s/ James P. Boylan | By James P. Boylan, Manager | 0001953107 |